BMPR2 and chondrosarcoma: The prognosis analysis showed that the rate of survival in chondrosarcoma patients was poor in case of higher expression levels of BMPR2 (Figure 1d), indicating that BMPR2 could be a prognostic marker for poor prognosis of chondrosarcomas.